130 related articles for article (PubMed ID: 23391494)
1. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
2. The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2013 Oct; 454(2):738-47. PubMed ID: 23603097
[TBL] [Abstract][Full Text] [Related]
3. Effect of the NFL-TBS.40-63 peptide on canine glioblastoma cells.
Audrey G; Claire LC; Joel E
Int J Pharm; 2021 Aug; 605():120811. PubMed ID: 34144141
[TBL] [Abstract][Full Text] [Related]
4. The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.
Lépinoux-Chambaud C; Eyer J
Int J Pharm; 2019 Jul; 566():218-228. PubMed ID: 31132447
[TBL] [Abstract][Full Text] [Related]
5. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
6. The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties.
Lépinoux-Chambaud C; Barreau K; Eyer J
Stem Cells Transl Med; 2016 Jul; 5(7):901-13. PubMed ID: 27177578
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament-tubulin binding site peptide NFL-TBS.40-63 increases the differentiation of oligodendrocytes in vitro and partially prevents them from lysophosphatidyl choline toxiciy.
Fressinaud C; Eyer J
J Neurosci Res; 2014 Feb; 92(2):243-53. PubMed ID: 24327347
[TBL] [Abstract][Full Text] [Related]
8. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
[TBL] [Abstract][Full Text] [Related]
9. The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell line.
Rivalin R; Lepinoux-Chambaud C; Eyer J; Savagner F
PLoS One; 2014; 9(6):e98473. PubMed ID: 24896268
[TBL] [Abstract][Full Text] [Related]
10. Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.
Griveau A; Alnemeh-Al Ali H; Jourdain MA; Dupont A; Eyer J
Int J Pharm X; 2022 Dec; 4():100127. PubMed ID: 36177093
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.
Gazaille C; Sicot M; Akiki M; Lautram N; Dupont A; Saulnier P; Eyer J; Bastiat G
Pharm Res; 2021 Apr; 38(4):681-691. PubMed ID: 33829340
[TBL] [Abstract][Full Text] [Related]
12. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
13. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
14. NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.
Carradori D; Saulnier P; Préat V; des Rieux A; Eyer J
J Control Release; 2016 Sep; 238():253-262. PubMed ID: 27503706
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
17. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
[TBL] [Abstract][Full Text] [Related]
18. Neurofilaments and NFL-TBS.40-63 peptide penetrate oligodendrocytes through clathrin-dependent endocytosis to promote their growth and survival in vitro.
Fressinaud C; Eyer J
Neuroscience; 2015 Jul; 298():42-51. PubMed ID: 25862585
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.
Fressinaud C; Thomas O; Umerska AM; Saulnier P
Neurochem Res; 2020 Nov; 45(11):2732-2748. PubMed ID: 32910302
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
